Literature DB >> 21210768

Membrane-binding properties of the Factor VIII C2 domain.

Valerie A Novakovic1, David B Cullinan, Hironao Wakabayashi, Philip J Fay, James D Baleja, Gary E Gilbert.   

Abstract

Factor VIII functions as a cofactor for Factor IXa in a membrane-bound enzyme complex. Membrane binding accelerates the activity of the Factor VIIIa-Factor IXa complex approx. 100000-fold, and the major phospholipid-binding motif of Factor VIII is thought to be on the C2 domain. In the present study, we prepared an fVIII-C2 (Factor VIII C2 domain) construct from Escherichia coli, and confirmed its structural integrity through binding of three distinct monoclonal antibodies. Solution-phase assays, performed with flow cytometry and FRET (fluorescence resonance energy transfer), revealed that fVIII-C2 membrane affinity was approx. 40-fold lower than intact Factor VIII. In contrast with the similarly structured C2 domain of lactadherin, fVIII-C2 membrane binding was inhibited by physiological NaCl. fVIII-C2 binding was also not specific for phosphatidylserine over other negatively charged phospholipids, whereas a Factor VIII construct lacking the C2 domain retained phosphatidyl-L-serine specificity. fVIII-C2 slightly enhanced the cleavage of Factor X by Factor IXa, but did not compete with Factor VIII for membrane-binding sites or inhibit the Factor Xase complex. Our results indicate that the C2 domain in isolation does not recapitulate the characteristic membrane binding of Factor VIII, emphasizing that its role is co-operative with other domains of the intact Factor VIII molecule.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21210768      PMCID: PMC3670696          DOI: 10.1042/BJ20101797

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  49 in total

1.  Residues 110-126 in the A1 domain of factor VIII contain a Ca2+ binding site required for cofactor activity.

Authors:  Hironao Wakabayashi; Jan Freas; Qian Zhou; Philip J Fay
Journal:  J Biol Chem       Date:  2004-01-13       Impact factor: 5.157

2.  Contribution of factor VIIIa A2 and A3-C1-C2 subunits to the affinity for factor IXa in factor Xase.

Authors:  P Vincent Jenkins; Julie L Dill; Qian Zhou; Philip J Fay
Journal:  Biochemistry       Date:  2004-05-04       Impact factor: 3.162

3.  Disruption of protein-membrane binding and identification of small-molecule inhibitors of coagulation factor VIII.

Authors:  P Clint Spiegel; Shari M Kaiser; Julian A Simon; Barry L Stoddard
Journal:  Chem Biol       Date:  2004-10

4.  A simple method for the preparation of homogeneous phospholipid vesicles.

Authors:  Y Barenholz; D Gibbes; B J Litman; J Goll; T E Thompson; R D Carlson
Journal:  Biochemistry       Date:  1977-06-14       Impact factor: 3.162

5.  Anticoagulant effects of a synthetic peptide containing residues Thr-2253-Gln-2270 within factor VIII C2 domain that selectively inhibits factor Xa-catalysed factor VIII activation.

Authors:  Keiji Nogami; Midori Shima; Katsumi Nishiya; Kazuya Hosokawa; Evgueni L Saenko; John C Giddings; Ichiro Tanaka; Akira Yoshioka
Journal:  Br J Haematol       Date:  2002-03       Impact factor: 6.998

6.  Characterization of the human factor VIII gene.

Authors:  J Gitschier; W I Wood; T M Goralka; K L Wion; E Y Chen; D H Eaton; G A Vehar; D J Capon; R M Lawn
Journal:  Nature       Date:  1984 Nov 22-28       Impact factor: 49.962

7.  Molecular cloning of a cDNA encoding human antihaemophilic factor.

Authors:  J J Toole; J L Knopf; J M Wozney; L A Sultzman; J L Buecker; D D Pittman; R J Kaufman; E Brown; C Shoemaker; E C Orr
Journal:  Nature       Date:  1984 Nov 22-28       Impact factor: 49.962

8.  The preparation and phospholipid binding property of the C2 domain of human factor VIII.

Authors:  Kazuya Takeshima; Christina Smith; Jonathan Tait; Kazuo Fujikawa
Journal:  Thromb Haemost       Date:  2003-05       Impact factor: 5.249

9.  Immunodominant T-cell epitopes in the factor VIII C2 domain are located within an inhibitory antibody binding site.

Authors:  Kathleen P Pratt; Jiahua Qian; Ekram Ellaban; David K Okita; Brenda M Diethelm-Okita; Bianca Conti-Fine; David W Scott
Journal:  Thromb Haemost       Date:  2004-09       Impact factor: 5.249

10.  Mutation of the surface-exposed amino acid Trp to Ala in the FVIII C2 domain results in defective secretion of the otherwise functional protein.

Authors:  Simone M Schatz; Klaus Zimmermann; Meinhard Hasslacher; Randolf Kerschbaumer; Michael Dockal; Herbert Gritsch; Peter L Turecek; Hans P Schwarz; Friedrich Dorner; Friedrich Scheiflinger
Journal:  Br J Haematol       Date:  2004-06       Impact factor: 6.998

View more
  12 in total

1.  In situ quantification of protein binding to the plasma membrane.

Authors:  Elizabeth M Smith; Jared Hennen; Yan Chen; Joachim D Mueller
Journal:  Biophys J       Date:  2015-06-02       Impact factor: 4.033

2.  Platelet binding sites for factor VIII in relation to fibrin and phosphatidylserine.

Authors:  Gary E Gilbert; Valerie A Novakovic; Jialan Shi; Jan Rasmussen; Steven W Pipe
Journal:  Blood       Date:  2015-07-10       Impact factor: 22.113

3.  Long-term correction of hemorrhagic diathesis in hemophilia A mice by an AAV-delivered hybrid FVIII composed of the human heavy chain and the rat light chain.

Authors:  Jianhua Mao; Yun Wang; Wei Zhang; Yan Shen; Guowei Zhang; Wenda Xi; Qiang Wang; Zheng Ruan; Jin Wang; Xiaodong Xi
Journal:  Front Med       Date:  2022-01-17       Impact factor: 9.927

4.  Domain organization of membrane-bound factor VIII.

Authors:  Svetla Stoilova-McPhie; Gillian C Lynch; Steven Ludtke; B Montgomery Pettitt
Journal:  Biopolymers       Date:  2013-07       Impact factor: 2.505

5.  Molecular orientation of factor VIIIa on the phospholipid membrane surface determined by fluorescence resonance energy transfer.

Authors:  Hironao Wakabayashi; Philip J Fay
Journal:  Biochem J       Date:  2013-06-01       Impact factor: 3.857

6.  Replacing the factor VIII C1 domain with a second C2 domain reduces factor VIII stability and affinity for factor IXa.

Authors:  Hironao Wakabayashi; Philip J Fay
Journal:  J Biol Chem       Date:  2013-09-12       Impact factor: 5.157

7.  Membrane Interaction of the Factor VIIIa Discoidin Domains in Atomistic Detail.

Authors:  Jesper J Madsen; Y Zenmei Ohkubo; Günther H Peters; Johan H Faber; Emad Tajkhorshid; Ole H Olsen
Journal:  Biochemistry       Date:  2015-09-30       Impact factor: 3.162

8.  The 3.2 Å structure of a bioengineered variant of blood coagulation factor VIII indicates two conformations of the C2 domain.

Authors:  Ian W Smith; Anne E d'Aquino; Christopher W Coyle; Andrew Fedanov; Ernest T Parker; Gabriela Denning; Harold Trent Spencer; Pete Lollar; Christopher B Doering; Paul Clint Spiegel
Journal:  J Thromb Haemost       Date:  2019-09-08       Impact factor: 5.824

9.  Dimeric Organization of Blood Coagulation Factor VIII bound to Lipid Nanotubes.

Authors:  Daniela Dalm; Jesus G Galaz-Montoya; Jaimy L Miller; Kirill Grushin; Alex Villalobos; Alexey Y Koyfman; Michael F Schmid; Svetla Stoilova-McPhie
Journal:  Sci Rep       Date:  2015-06-17       Impact factor: 4.379

10.  Antibacterial membrane attack by a pore-forming intestinal C-type lectin.

Authors:  Sohini Mukherjee; Hui Zheng; Mehabaw G Derebe; Keith M Callenberg; Carrie L Partch; Darcy Rollins; Daniel C Propheter; Josep Rizo; Michael Grabe; Qiu-Xing Jiang; Lora V Hooper
Journal:  Nature       Date:  2013-11-20       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.